Pregnancy and infant outcomes post–CD19-directed CAR-T therapy: Tisagenlecleucel (tisa-cel) and/or huCAR19 (CTL119).

Authors: Stephan A. Grupp, Dana B. Salzberg, Marianne Ifversen, Julie Anna Wolfson, Mara Constantinescu, Andrea Jegerlehner, Rakesh Awasthi, Jennifer Willert, Noelle V. Frey, Andy I. Chen

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.7029

Source: Full article

---

Abstract

7029